Anthony Martinelli

Anthony Martinelli is founder and Editor-in-Chief of The Marijuana Herald. Anthony previously served as Editor-in-Chief of TheJointBlog.com (a cannabis news site he founded in 2011 and sold in 2019), and he has worked as a campaign manager and communications director for multiple political campaigns and elected officials. Anthony can be reached at Info@TheMarijuanaHerald.com.

Author's posts

Study: CBD May Improve Memory and Reduce Inflammation in Alzheimer’s Patients

A study from the University of Haifa, published in the journal Neuropsychopharmacology, has found that cannabidiol (CBD) reduced both cognitive decline and neuroinflammation in an animal model of Alzheimer’s disease. For the study, researchers worked with rats bred to mimic Alzheimer’s disease, which caused memory loss, reduced social interaction, and brain changes linked to the …

Continue reading

Clinical Trial: Psilocybin-Assisted Psychotherapy Reduces Depression and Anxiety in Patients With Life-Threatening Illness

In a phase 2b randomized controlled trial, psilocybin-assisted psychotherapy provided significant and lasting relief from depression and anxiety in people with life-threatening illnesses. The study, conducted by researchers from St. Vincent’s Hospital Melbourne, Swinburne University, and the University of Melbournem, enrolled 35 participants between 18 and 80 who were experiencing clinically significant depression or anxiety. …

Continue reading

Nearly One Million Records Exposed in Ohio Marijuana Card Data Breach

A major data breach has exposed nearly one million records tied to Ohio Marijuana Card, a company that helps patients secure physician-certified medical marijuana cards through telehealth and in-person clinics across several states. The incident, impacting 957,434 records, was first discovered on July 14, 2025, by cybersecurity researcher Jeremiah Fowler, and was announced today via …

Continue reading

2025 Cannabis Research: A Breakdown of Over 250 Studies

The pace of cannabis research in 2025 has been unprecedented. Through the end of August, scientists around the world have released hundreds of peer-reviewed studies exploring nearly every facet of the plant and its compounds. This wave of research reflects both a growing acceptance of marijuana as a subject of serious academic inquiry and the …

Continue reading

Study: CBDA Shows Far Greater Bioavailability Than CBD in Animal and Cell Models

Researchers from the University of Chemistry and Technology Prague and the Institute for Clinical and Experimental Medicine have found that cannabidiolic acid (CBDA) has far stronger bioavailability than cannabidiol (CBD), making it a potentially underutilized therapeutic compound. The study, which is being published in the November 2025 issue of the International Journal of Pharmaceutics, tested …

Continue reading

Study: No Significant Change in Car Accidents Following Cannabis Legalization in Connecticut

A new peer-reviewed study has found that Connecticut’s move to legalize recreational cannabis in 2023 did not lead to an increase in car accidents, either across the state or in neighborhoods surrounding dispensaries. Published in Cannabis and Cannabinoid Research and made available online by the U.S. National Library of Medicine, the research adds to the …

Continue reading

The Five States Most Likely to Legalize Recreational Cannabis in 2026

Given most state legislatures are currently on recess, talks surrounding state-level cannabis legalization efforts have slowed for a moment. That said, as 2026 fast approaches, efforts to legalize recreational cannabis is heating up in multiple states. Shifting politics, growing public support, and new legislative proposals are putting several states in the spotlight as the next …

Continue reading

Study: 1 in 12 U.S. Cancer Survivors Use Marijuana, Nearly Half for Medical Purposes

A nationwide analysis has found that roughly 1 in 12 cancer survivors in the United States use marijuana, with medical use being far more common among this group than the general population. The study, published in JCO Oncology Practice, reviewed survey data from more than 82 million adults across 23 states who responded to the …

Continue reading

U.S. Congress: Republican Bill Would Regulate Hemp Products Nationally, Set Age Limit at 21

Congressman Morgan Griffith (R-VA) has begun circulating a draft proposal that would create a clear federal regulatory framework for consumable hemp items such as beverages, edibles, and inhalable, while establishing a minimum age of 21. According to details being shared by the Hemp Beverage Alliance, which is gathering feedback on the plan, products could not …

Continue reading

Massachusetts Marijuana Sales Surpass $1.16 Billion in 2025 Through August 24, Over 15% Increase From 2024

Massachusetts’ marijuana market has generated over $1.16 billion in sales so far this year, an over 10% increase from the same period in 2024. From January 1 through August 24, licensed recreational marijuana retailers reported $1.06 billion in sales. July marked the strongest month of the year at $144.1 million, while May and June also …

Continue reading